Koninklijke Philips NVRYLPF 73 PEG Ratio is 2.73 as of Jun. 24, 2026, which is 90% below its 10-year median of 28.58. GuruFocus rates RYLPF with a GF Score™ of 73/100 and a GF Value™ of $25.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 206 Medical Devices & Instruments companies, Koninklijke Philips NV ranks worse than 67.48% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Koninklijke Philips NV's PEG Ratio or its related term are showing as below:
RYLPF'
s PEG Ratio Range Over the Past 10 Years
Min: 2.73 Med: 28.58 Max: 38.25
Current: 2.73
During the past 13 years, Koninklijke Philips NV's highest PEG Ratio was 38.25. The lowest was 2.73. And the median was 28.58.
RYLPF's PEG Ratio is ranked worse than 67.48% of 206
companies
in the Medical Devices & Instruments industry
Industry Median: 1.95
vs RYLPF: 2.73
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Koninklijke Philips NV (OTCPK:RYLPF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Koninklijke Philips NV's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Koninklijke Philips NV (RYLPF) has a PEG Ratio of 2.73 as of Jun. 24, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Koninklijke Philips NV and its competitors. This is 90% below median its historical median of 28.58. Over the past decade, Koninklijke Philips NV's PEG Ratio has ranged from 2.73 to 38.25. According to the industry distribution chart, Koninklijke Philips NV ranks #139 out of 206 companies in the Medical Devices & Instruments industry, placing it in the top 67.5%.
Is Koninklijke Philips NV's PEG Ratio too high?
Koninklijke Philips NV's current PEG Ratio of 2.73 is 90% below median its 10-year median of 28.58. Over the past 10 years, this metric has ranged from a low of 2.73 to a high of 38.25. The Medical Devices & Instruments industry median PEG Ratio is 1.95. Koninklijke Philips NV's value of 2.73 is 40% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #139 out of 206 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #139 out of 206 companies for PEG Ratio. This places Koninklijke Philips NV in the lower half of its industry. The industry median PEG Ratio is 1.95. Koninklijke Philips NV's value of 2.73 is 40% above this benchmark. Historically, Koninklijke Philips NV's own PEG Ratio has ranged from 2.73 to 38.25 over the past decade. While the company's 10-year median is 28.58 vs. the industry median of 1.95, Koninklijke Philips NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.95, based on 206 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current PEG Ratio of 2.73 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current PEG Ratio is 2.73, which is 90% below median its own 10-year median of 28.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.13, compared to a current price of $26.19 — trading 4.2% above its estimated fair value. The current PEG Ratio is 2.73, which is 90% below median its 10-year median of 28.58 and 40% above the Medical Devices & Instruments industry median of 1.95. Koninklijke Philips NV's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current PEG Ratio is 2.73 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $26.19 is trading 4.2% above its estimated GF Value™ of $25.13.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
PEG Ratio: 2.73 (90% below median its 10-year median of 28.58)
GF Value™: $25.13 vs. price of $26.19 (4.2% above fair value)
Industry Position: 40% above the Medical Devices & Instruments median (#139 of 206)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
73GF Score
Get the complete analysis for RYLPF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
